WASHINGTON—In response to the widespread devastation caused by the wildfires across the Los Angeles area, AARP Foundation has launched a disaster relief campaign to provide critical aid to those...

Today, AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement in response to the Centers for Medicare & Medicaid Services (CMS) announcement of the next 15 drugs selected to have their prices negotiated by Medicare

A new AARP survey of people age 50 and older released today reveals that 24% of older workers are planning to make a job change this year, a 10% increase from last year, when just 14% indicated they were looking for new employment. These findings are consistent with recent research showing more Americans are looking to switch jobs than at any point in the past decade.

WASHINGTON — A new report out from AARP today provides additional insight into the impact of a historic new financial protection for our nation’s nearly 55 million Medicare drug plan enrollees. For the first time ever, beginning January 1, 2025, Medicare drug plans will limit enrollees’ annual out-of-pocket spending to $2,000, thanks to a provision in the 2022 Inflation Reduction Act that AARP championed. Specifically, the report shows that 94% of all Part D enrollees expected to reach the new cap in 2025 will have lower total (i.e., premiums and cost sharing) out-of-pocket costs, saving an average of $2,474 nationally. The report also provides state-level data and estimates that 95% of Part D enrollees who will reach the out-of-pocket cap will have lower out-of-pocket health costs in 33 states plus the District of Columbia.